Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Granules India's annualized net income for the quarter that ended in Dec. 2023 was ₹5,026 Mil. Granules India's average shareholder tangible equity for the quarter that ended in Dec. 2023 was ₹26,920 Mil. Therefore, Granules India's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 18.67%.
The historical rank and industry rank for Granules India's Return-on-Tangible-Equity or its related term are showing as below:
NSE:GRANULES'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.65 Med: 25.65 Max: 32.9
Current: 15.77
During the past 13 years, Granules India's highest Return-on-Tangible-Equity was 32.90%. The lowest was 15.65%. And the median was 25.65%.
NSE:GRANULES's Return-on-Tangible-Equity is ranked better than 75.66% of 945
companies
in the Drug Manufacturers industry
Industry Median: 6.72
vs NSE:GRANULES: 15.77
Granules India Return-on-Tangible-Equity Historical Data
The historical data trend for Granules India's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Granules India's Return-on-Tangible-Equity
For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Granules India's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Granules India's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Granules India's Return-on-Tangible-Equity falls into.
Granules India Return-on-Tangible-Equity Calculation
Granules India's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2023) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Granules India (NSE:GRANULES) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Granules India Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Granules India's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Granules India (NSE:GRANULES) Business Description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:GRANULES has been successfully added to your 